Bank of America
TARO

Bank of America’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bank of America’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,230
Closed -$179K – 8509
2024
Q1 		$179K Sell
4,230
-4,935
-54% -$208K ﹤0.01% 5937
2023
Q4 		$383K Sell
9,165
-1,882
-17% -$69.4K ﹤0.01% 5682
2023
Q3 		$417K Buy
11,047
+2,671
+32% +$100K ﹤0.01% 5436
2023
Q2 		$318K Buy
8,376
+6,870
+456% +$216K ﹤0.01% 5549
2023
Q1 		$36.6K Buy
1,506
+841
+126% +$24.5K ﹤0.01% 6590
2022
Q4 		$19.3K Sell
665
-198
-23% -$5.87K ﹤0.01% 6749
2022
Q3 		$26K Sell
863
-26
-3% -$897 ﹤0.01% 6941
2022
Q2 		$32K Sell
889
-45
-5% -$1.72K ﹤0.01% 7031
2022
Q1 		$40K Sell
934
-16
-2% -$748 ﹤0.01% 7270
2021
Q4 		$47K Buy
950
+202
+27% +$11.3K ﹤0.01% 7247
2021
Q3 		$47K Sell
748
-217
-22% -$15K ﹤0.01% 7077
2021
Q2 		$70K Sell
965
-203
-17% -$14.9K ﹤0.01% 6693
2021
Q1 		$86K Sell
1,168
-28
-2% -$2.13K ﹤0.01% 6453
2020
Q4 		$88K Buy
1,196
+893
+295% +$57.4K ﹤0.01% 6051
2020
Q3 		$16K Hold
303
– – ﹤0.01% 6345
2020
Q2 		$20K Sell
303
-1,804
-86% -$121K ﹤0.01% 6268
2020
Q1 		$130K Buy
2,107
+1,922
+1,039% +$142K ﹤0.01% 5372
2019
Q4 		$16K Buy
185
+134
+263% +$11.3K ﹤0.01% 6550
2019
Q3 		$4K Hold
51
– – ﹤0.01% 6906
2019
Q2 		$4K Sell
51
-3
-6% -$297 ﹤0.01% 6879
2019
Q1 		$6K Buy
54
+3
+6% +$299 ﹤0.01% 6772
2018
Q4 		$4K Hold
51
– – ﹤0.01% 6805
2018
Q3 		$5K Sell
51
-458
-90% -$49.6K ﹤0.01% 6842
2018
Q2 		$59K Sell
509
-4,369
-90% -$480K ﹤0.01% 6055
2018
Q1 		$482K Sell
4,878
-1,883
-28% -$191K ﹤0.01% 4835
2017
Q4 		$708K Sell
6,761
-12,101
-64% -$1.33M ﹤0.01% 4706
2017
Q3 		$2.13M Sell
18,862
-2,932
-13% -$319K ﹤0.01% 3934
2017
Q2 		$2.44M Buy
21,794
+1,223
+6% +$138K ﹤0.01% 3702
2017
Q1 		$2.4M Buy
20,571
+633
+3% +$70.1K ﹤0.01% 3717
2016
Q4 		$2.1M Buy
19,938
+8,060
+68% +$844K ﹤0.01% 3734
2016
Q3 		$1.31M Buy
11,878
+2,182
+23% +$289K ﹤0.01% 3958
2016
Q2 		$1.41M Sell
9,696
-44
-0.5% -$6.24K ﹤0.01% 3909
2016
Q1 		$1.4M Buy
9,740
+8,184
+526% +$1.16M ﹤0.01% 3870
2015
Q4 		$241K Buy
1,556
+1,487
+2,155% +$217K ﹤0.01% 5268
2015
Q3 		$10K Sell
69
-1,920
-97% -$268K ﹤0.01% 6573
2015
Q2 		$286K Sell
1,989
-447
-18% -$63.7K ﹤0.01% 5063
2015
Q1 		$344K Buy
2,436
+361
+17% +$55.6K ﹤0.01% 4570
2014
Q4 		$307K Buy
2,075
+1,987
+2,258% +$292K ﹤0.01% 5016
2014
Q3 		$14K Sell
88
-412
-82% -$62K ﹤0.01% 7210
2014
Q2 		$70K Sell
500
-753
-60% -$83.6K ﹤0.01% 6402
2014
Q1 		$139K Buy
1,253
+653
+109% +$71.1K ﹤0.01% 5717
2013
Q4 		$59K Hold
600
– – ﹤0.01% 6467
2013
Q3 		$46K Sell
600
-2,100
-78% -$136K ﹤0.01% 6478
2013
Q2 		$151K Buy
+2,700
New +$160K ﹤0.01% 5876

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Bank of America's TARO Position: Q2 2024 in Review

Bank of America sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 4,230 shares — an estimated $179K sold.

Bank of America first reported a position in TARO in Q2 2013 and held it in 44 quarters. The position peaked at $2.44M in Q2 2017. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Bank of America reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 4,230 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $179K.
  • Bank of America first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 44 quarters.
  • Bank of America's Taro Pharmaceutical Industries Ltd. position peaked at $2.44M in Q2 2017.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.